SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-18-319597
Filing Date
2018-11-06
Accepted
2018-11-06 16:24:10
Documents
5

Document Format Files

Seq Description Document Type Size
1 S-3 d646564ds3.htm S-3 171500
2 EX-5.1 d646564dex51.htm EX-5.1 10788
3 EX-23.1 d646564dex231.htm EX-23.1 1686
4 GRAPHIC g646564g05c73.jpg GRAPHIC 14930
5 GRAPHIC g646564g60i36.jpg GRAPHIC 10293
  Complete submission text file 0001193125-18-319597.txt   219959
Mailing Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 415-365-5600
FIVE PRIME THERAPEUTICS INC (Filer) CIK: 0001175505 (see all company filings)

IRS No.: 260038620 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-228206 | Film No.: 181163310
SIC: 2834 Pharmaceutical Preparations